Esteban Tesson

Palantir beats estimates on AI momentum and rising government demand

03 February 2026 at 08:35 am AEDT

Wall Street is upbeat about the earnings ahead

U.S. stock markets started the week on a positive note on Monday, lifted by investor optimism ahead of a series of major earnings releases expected in the coming days.

03 February 2026 at 08:19 am AEDT

Brookfield to Acquire Peakstone Realty Trust for $1.2bn

03 February 2026 at 02:39 am AEDT

Rare earth stocks soar as Washington prepares strategic reserves

03 February 2026 at 02:19 am AEDT

Brookfield to Acquire Peakstone Realty Trust for $1.2bn

03 February 2026 at 02:18 am AEDT

Washington Prepares a Strategic Rare Earths Reserve, Sector Stocks Surge

03 February 2026 at 01:41 am AEDT

Nvidia's shares weakened by doubts over its partnership with OpenAI

03 February 2026 at 12:18 am AEDT

Nvidia shares weakened by doubts over its OpenAI partnership

03 February 2026 at 12:09 am AEDT

Wall Street slips amid uncertainty over the Fed, inflation and corporate earnings

U.S. markets ended Friday's session lower, in a jittery atmosphere marked by mounting monetary-policy uncertainty, unsettling inflation data and a mixed run of corporate releases. Donald Trump's appointment of Kevin Warsh as Federal Reserve chair acted as a catalyst for volatility, also triggering a sharp correction in precious metals.

31 January 2026 at 08:10 am AEDT

Verizon expects sharp earnings growth as subscriber adds rebound

31 January 2026 at 03:40 am AEDT

Exxon says it will return to Venezuela only if country becomes democratic again

31 January 2026 at 03:24 am AEDT

Verizon expects a sharp rise in earnings on renewed subscriber momentum

31 January 2026 at 03:01 am AEDT

Exxon Ties Any Return to Venezuela to a Democratic Transition

31 January 2026 at 02:25 am AEDT

Regeneron beats expectations on Dupixent strength despite pressure on Eylea

On Friday Regeneron Pharmaceuticals posted quarterly results that exceeded forecasts, driven by strong growth in Dupixent, its flagship treatment jointly developed with Sanofi. Dupixent sales rose 34% to $4.9bn, in line with market estimates. As Eylea revenue falls amid tougher competition and regulatory constraints, Dupixent is emerging as the group's main growth engine.

31 January 2026 at 02:02 am AEDT

Regeneron beats expectations on Dupixent, despite pressure on Eylea

Regeneron Pharmaceuticals on Friday reported quarterly results that topped forecasts, driven by strong growth in Dupixent, its flagship treatment co-developed with Sanofi. Dupixent sales rose 34% to $4.9bn, in line with market estimates. As Eylea revenue declines amid tougher competition and regulatory constraints, Dupixent is emerging as the company's main growth engine.

31 January 2026 at 12:36 am AEDT

Apple acquires startup Q.ai to bolster its audio AI capabilities

30 January 2026 at 07:07 pm AEDT

Amazon considers investing up to $50bn in OpenAI to bolster its AI strategy

30 January 2026 at 06:51 pm AEDT

Apple: results beat estimates, thanks to record iPhone 17 sales

30 January 2026 at 06:45 pm AEDT

Amazon Is Said to Be Considering Investing Up to $50bn in OpenAI, Strengthening Its AI Strategy

30 January 2026 at 08:58 am AEDT

Apple posts results above expectations on record iPhone 17 sales

30 January 2026 at 08:43 am AEDT

Apple posts better-than-expected results on record iPhone 17 sales

30 January 2026 at 08:41 am AEDT